The new segment will be responsible for the research, analysis and production of OEM components for all cardiovascular products including cardiac and peripheral stents, vascular grafts and stent grafts, vascular access devices, pacemakers, and accessory products for heart valves.

US BioDesign said its focus on the medical construct solution has facilitated customers to use its components into their devices, quickly and efficiently, thus shortening the overall development and delivery timelines

US BioDesign CEO Tom Molz said they are pleased that they are having quite a bit of initial success, especially in the cardiovascular area.